MEDTECH

SUMMIT & AWARDS

CELL 101 INTERNATIONAL

Cell 101 International Sdn . Bhd . is a leading Malaysian Cellular Biotechnology company that is paving the way towards enhancement , establishment and regulation of cellular , regenerative & preventive medical technologies as well as therapies . Cell 101 ’ s headquarters is currently residing in one of the most distinguished research wings of Universiti Malaya , nestled in the heart of Kuala Lumpur , which highlights our strong collaboration with this world-renowned institution . Cell 101 is also in the midst of establishing the first of its kind Biotech Training Facility as well as a state of the art Research & Production Facility that will showcase some of the most advanced technologies in its facility throughout Asia-Pacific .

Our mission is to provide a high-value unit in the next scientific revolution with a vision to be one of the most trusted and reputable organizations in the biotechnology industry . Cell 101 aims to be the benchmark in this fast-paced industry , setting guidelines and protocols to lead cellular biotech to greater heights . It is no mystery today that cellular technology and therapies are being widely used all around the world , with many positive results and success stories .

However , there is still a lack of understanding and awareness amongst both providers and recipients , thus creating a gap that needs to be filled . Cell 101 aims to provide the ultimate solution and bridge both the scientific and medical worlds pertaining cellular tech and concepts .

Our upcoming facility will showcase

Muhammad Mazli Bin Md Ali

a modular laboratory mechanism , taking sterility and safety of cellular based products to the next level . This technology will be the first of its kind in Asia-Pacific , and Cell 101 intends to introduce this concept not just in Malaysia but to other neighbouring countries as well . Using a cyto-centric mechanism , full focus and priority will be given to the culture methods and transportation of all cellular products , reducing any form of contamination and ensuring more stable outcomes . This will be the stepping stone in creating an international guideline and to serve as the benchmark for production & culture of cellular products . Due to complete by the end of 2024 , it is a project that we are all looking forward to .

Our products include the cutting edge Human Wharton-Jelly Stem Cells for clinical trials and regenerative therapy , immune cells such as Natural KiIller Cells , exosomes and other growth factors , epigenetic profiling of biological age and other active nutraceutical ingredients for various applications with international logistics and sales . Our target clients are functional and lifestyle medicine clinics , medical centers , hospitals and other biotech companies .

Besides , we are also involved in designing industry relevant bespoke curriculum and training programmes in the areas of biotechnology , molecular biology , regenerative medicine and healthcare for academic and professional certificate programs .

We have formed a cohesive and comprehensive support unit for our clients and business partners , allowing them to participate and grow with us for mutual benefit as well as to provide optimal solutions for the public . With all the resources and data that we have amassed , it is undeniable that cellular biotechnology will be the next big thing in the medical & scietific arenas , opening up tremendous opportunities for providers and related businesses . Utilizing the best methods and technologies is undeniably the key to determining the future of cellular biotechnology . Cell 101 is at the forefront of cellular biotechnology and is ready to serve its clients and partners to its fullest capacity .

84 SPECIAL ISSUE | 2024 GlobalHealthAsiaPacific . com